1. Home
  2. CNTA vs PLUS Comparison

CNTA vs PLUS Comparison

Compare CNTA & PLUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CNTA
  • PLUS
  • Stock Information
  • Founded
  • CNTA 2020
  • PLUS 1990
  • Country
  • CNTA United Kingdom
  • PLUS United States
  • Employees
  • CNTA N/A
  • PLUS N/A
  • Industry
  • CNTA Biotechnology: Pharmaceutical Preparations
  • PLUS Retail: Computer Software & Peripheral Equipment
  • Sector
  • CNTA Health Care
  • PLUS Technology
  • Exchange
  • CNTA Nasdaq
  • PLUS Nasdaq
  • Market Cap
  • CNTA 1.6B
  • PLUS 1.9B
  • IPO Year
  • CNTA 2021
  • PLUS 1996
  • Fundamental
  • Price
  • CNTA $14.29
  • PLUS $70.16
  • Analyst Decision
  • CNTA Strong Buy
  • PLUS
  • Analyst Count
  • CNTA 10
  • PLUS 0
  • Target Price
  • CNTA $28.78
  • PLUS N/A
  • AVG Volume (30 Days)
  • CNTA 980.2K
  • PLUS 226.8K
  • Earning Date
  • CNTA 08-12-2025
  • PLUS 08-05-2025
  • Dividend Yield
  • CNTA N/A
  • PLUS N/A
  • EPS Growth
  • CNTA N/A
  • PLUS N/A
  • EPS
  • CNTA N/A
  • PLUS 4.05
  • Revenue
  • CNTA $15,000,000.00
  • PLUS $2,068,789,000.00
  • Revenue This Year
  • CNTA N/A
  • PLUS $3.88
  • Revenue Next Year
  • CNTA N/A
  • PLUS $2.84
  • P/E Ratio
  • CNTA N/A
  • PLUS $17.51
  • Revenue Growth
  • CNTA 118.88
  • PLUS N/A
  • 52 Week Low
  • CNTA $9.00
  • PLUS $53.83
  • 52 Week High
  • CNTA $19.09
  • PLUS $106.98
  • Technical
  • Relative Strength Index (RSI)
  • CNTA 61.38
  • PLUS 46.75
  • Support Level
  • CNTA $13.22
  • PLUS $69.86
  • Resistance Level
  • CNTA $14.74
  • PLUS $72.37
  • Average True Range (ATR)
  • CNTA 0.73
  • PLUS 2.05
  • MACD
  • CNTA 0.14
  • PLUS -0.43
  • Stochastic Oscillator
  • CNTA 85.11
  • PLUS 9.62

About CNTA Centessa Pharmaceuticals plc

Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.

About PLUS ePlus inc.

ePlus Inc is a provider of technology solutions across the IT spectrum, spanning security, cloud, data center, networking, collaboration, AI, service provider, and critical infrastructure, and emerging solutions, to domestic and foreign organizations across all industry segments. Its solutions leverage a broad range of professional, consultative, and managed services across the technology spectrum. The company possesses top-level engineering certifications with a broad range of IT technologies that enable the company to offer multi-vendor IT solutions that are optimized for each of its customers' specific requirements. It also offers a wide portfolio of technology and other capital asset financing solutions to customers across commercial and government enterprises, designing programs.

Share on Social Networks: